Work

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma

Year: 2012

Type: article

Study design: Observational Study

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2012.02.050

Authors: Daniel Keizman, Maya Ish-Shalom, Roberto Pili, Hans Hammers, Mario A. Eisenberger, Victoria Sinibaldi, Ben Boursi, Natalie Maimon, Maya Gottfried, Henry Hayat, Avivit Peer, Svetlana Kovel, Avishay Sella, Raanan Berger, Michael A. Carducci

Institutions: Tel Aviv University, Meir Medical Center, Roswell Park Comprehensive Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Sheba Medical Center, Wolfson Medical Center, Rambam Health Care Campus, Assaf Harofeh Medical Center

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1999556452

FWCI: 5.216

Cites: 24

Cited by: 54

Related to: 10